Brighton Jones’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.51M Buy
80,361
+25,252
+46% +$1.17M 0.06% 199
2026
Q2
$2.35M Buy
55,109
+8,121
+17% +$441K 0.04% 261
2026
Q1
$2.95M Buy
+46,988
New +$3.76M 0.07% 209
2025
Q4
– Sell
-28,559
Closed -$2.79M – 173
2025
Q3
$2.79M Sell
28,559
-3,282
-10% -$340K 0.07% 166
2025
Q2
$3.42M Buy
31,841
+4,377
+16% +$443K 0.09% 129
2025
Q1
$2.77M Buy
27,464
+88
+0.3% +$8.86K 0.09% 131
2024
Q4
$2.45M Buy
27,376
+226
+0.8% +$19.9K 0.07% 144
2024
Q3
$2.28M Buy
27,150
+10,132
+60% +$799K 0.09% 121
2024
Q2
$1.31M Buy
17,018
+12,091
+245% +$885K 0.04% 196
2024
Q1
$337K Buy
4,927
+574
+13% +$36.9K 0.01% 434
2023
Q4
$252K Buy
4,353
+354
+9% +$18.9K 0.01% 479
2023
Q3
$211K Buy
3,999
+205
+5% +$10.8K 0.01% 488
2023
Q2
$205K Buy
+3,794
New +$198K 0.01% 503

Other funds holding BSX

Brighton Jones's BSX Position: Q3 2026 in Review

Brighton Jones increased its Boston Scientific (BSX) stake by 46% in Q3 2026, buying an estimated $1.17M and bringing the position to 80,361 shares worth $3.51M. The position accounts for 0.06% of the portfolio, ranked #199.

Brighton Jones first reported a position in BSX in Q2 2023 and has held it in 13 quarters since. 1,274 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Brighton Jones held 80,361 shares of Boston Scientific worth $3.51M as of Q3 2026.
  • Brighton Jones bought 25,252 Boston Scientific shares in Q3 2026, an estimated $1.17M.
  • Boston Scientific made up 0.06% of Brighton Jones's portfolio in Q3 2026, its #199 holding.
  • Brighton Jones first reported a position in Boston Scientific in Q2 2023 and has held it in 13 quarters since.
  • 1,274 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.